Table 2 Distribution of pathologic stage groups after surgery
|  | Socazolimab + TP (n = 29) | Placebo + TP (n = 29) |
|---|---|---|
Pathologic T Stage | ||
 T0 | 11 (37.9) | 1 (3.4) |
 Tis/T1 | 5 (17.2) | 13 (44.8) |
 T2 | 5 (17.2) | 4 (13.8) |
 T3 | 8 (27.6) | 11 (37.9) |
Pathologic N Stage | ||
 N0 | 20 (69.0) | 21 (72.4) |
 N1 | 7 (24.1) | 3 (10.3) |
 N2 | 1 (3.4) | 4 (13.8) |
 N3 | 1 (3.4) | 1 (3.4) |
Pathologic Stage | ||
 I | 17 (58.6) | 17 (58.6) |
 II | 3 (10.3) | 4 (13.8) |
 IIIA | 4 (13.8) | 0 (0.0) |
 IIIB | 4 (13.8) | 7 (24.1) |
 IVA | 1 (3.6) | 1 (3.4) |